Login to Your Account



AIDS 2012 Vaccine

Analysis Adds to Understanding of RV144 Vaccine Trial Results

By Anette Breindl
Science Editor

Wednesday, September 12, 2012

Analyses of the RV144 HIV vaccine trial have analyzed viral variants that were able to get past the protection the vaccine offered. Those results, presented at the AIDS Vaccine 2012 conference, add to the emerging understanding that targeting certain parts of HIV's envelope protein is likely the best path to an effective vaccine.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription